Janet A Englund

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients
    Janet A Englund
    Children s Hospital and Regional Medical Center, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98105, USA
    Ann Intern Med 144:344-9. 2006
  2. ncbi Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers
    Janet A Englund
    Pediatric ID, Children s Hospital and Regional Medical Center, 4800 Sand Point Way, NE W8851, Seattle, Washington 98105, USA
    Pediatrics 118:e579-85. 2006
  3. ncbi Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study
    Janet A Englund
    Department of Pediatrics, Division of Infectious Diseases, Children s Hospital Research Institute, University of Washington, Seattle, WA, USA
    Pediatr Infect Dis J 29:105-10. 2010
  4. ncbi Maternal immunization with Haemophilus influenzae type b vaccines in different populations
    Janet A Englund
    Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way NE 8G, Seattle, WA 98105, USA
    Vaccine 21:3455-9. 2003
  5. ncbi Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT
    Angela P Campbell
    Department of Pediatrics, University of Washington, Seattle, Washington, USA
    J Infect Dis 201:1404-13. 2010
  6. ncbi WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients
    Jane Kuypers
    University of Washington, Seattle, Washington 98102, USA
    Emerg Infect Dis 18:1580-8. 2012
  7. ncbi Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients
    Su Mi Choi
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    J Infect Dis 206:1872-7. 2012
  8. ncbi Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
    Angela J Peck
    Department of Pediatrics, Children s Hospital and Regional Medical Center and University of Washington, Seattle, WA, USA
    Blood 110:1681-8. 2007
  9. ncbi Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study
    Emmanuel B Walter
    Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Pediatr Infect Dis J 28:1099-104. 2009
  10. ncbi Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Emmanuel B Walter
    Duke Clinical Research Institute, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
    Pediatrics 118:e570-8. 2006

Detail Information

Publications54

  1. ncbi Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients
    Janet A Englund
    Children s Hospital and Regional Medical Center, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98105, USA
    Ann Intern Med 144:344-9. 2006
    ..Human metapneumovirus (hMPV), a recently discovered respiratory virus, is associated with clinical disease in young and elderly persons...
  2. ncbi Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers
    Janet A Englund
    Pediatric ID, Children s Hospital and Regional Medical Center, 4800 Sand Point Way, NE W8851, Seattle, Washington 98105, USA
    Pediatrics 118:e579-85. 2006
    ....
  3. ncbi Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study
    Janet A Englund
    Department of Pediatrics, Division of Infectious Diseases, Children s Hospital Research Institute, University of Washington, Seattle, WA, USA
    Pediatr Infect Dis J 29:105-10. 2010
    ..Infants less than 6 months of age are at high risk for influenza disease and influenza-related complications, but no vaccine is licensed for this population...
  4. ncbi Maternal immunization with Haemophilus influenzae type b vaccines in different populations
    Janet A Englund
    Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way NE 8G, Seattle, WA 98105, USA
    Vaccine 21:3455-9. 2003
    ..Principles observed in these studies have potential application against other important neonatal pathogens...
  5. ncbi Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT
    Angela P Campbell
    Department of Pediatrics, University of Washington, Seattle, Washington, USA
    J Infect Dis 201:1404-13. 2010
    ..Few data exist on respiratory virus quantitation in lower respiratory samples and detection in serum from hematopoietic cell transplant (HCT) recipients with respiratory virus-associated pneumonia...
  6. ncbi WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients
    Jane Kuypers
    University of Washington, Seattle, Washington 98102, USA
    Emerg Infect Dis 18:1580-8. 2012
    ..There were no associations with polyomavirus detection and acute graft versus host disease, cytomegalovirus reactivation, neutropenia, lymphopenia, hospitalization, or death...
  7. ncbi Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients
    Su Mi Choi
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    J Infect Dis 206:1872-7. 2012
    ..Among patients with LRD, viremia was associated with increased hazards of overall and influenza-associated death (hazard ratio 3.5, 1.1-12). Thus, influenza viremia may serve as marker for overall poor outcome...
  8. ncbi Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
    Angela J Peck
    Department of Pediatrics, Children s Hospital and Regional Medical Center and University of Washington, Seattle, WA, USA
    Blood 110:1681-8. 2007
    ..004). Subclinical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV...
  9. ncbi Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study
    Emmanuel B Walter
    Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Pediatr Infect Dis J 28:1099-104. 2009
    ..Although children less than 6 months of age have the highest risk for hospitalization related to influenza infection, influenza vaccine is not approved for these children...
  10. ncbi Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Emmanuel B Walter
    Duke Clinical Research Institute, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
    Pediatrics 118:e570-8. 2006
    ....
  11. ncbi Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care
    Min Xu
    Dept of Laboratories, Seattle Children s Hospital, Seattle, WA 98105, USA
    Am J Clin Pathol 139:118-23. 2013
    ..Our results demonstrate that molecular technology can be successfully deployed in a nonspecialty, high-volume, multidisciplinary core laboratory...
  12. ncbi Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
    Filippo Milano
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 115:2088-94. 2010
    ..HRV and HCoV infections are common in the first 100 days after HCT, viral shedding lasts more than 3 weeks in half, and lower respiratory infection is rare...
  13. ncbi Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study
    Debie Vu
    Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 1024, USA
    Clin Infect Dis 45:187-93. 2007
    ..However, no data exist regarding the use of oseltamivir as prophylaxis among patients undergoing hematopoietic stem cell transplantation (HSCT)...
  14. ncbi Influenza-associated morbidity in children with cancer
    Sarah K Tasian
    Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Pediatr Blood Cancer 50:983-7. 2008
    ..The clinical impact of influenza in children undergoing therapy for cancer is not well-described in the literature...
  15. ncbi Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus
    Emily T Martin
    Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
    Diagn Microbiol Infect Dis 62:382-8. 2008
    ..Our study has described a significant relationship between viral load and markers of disease severity for both RSV and hMPV in a large population of children evaluated for respiratory disease...
  16. ncbi Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients
    Christian Renaud
    Seattle Children s Hospital, Seattle, WA, USA
    Antivir Ther 17:175-91. 2012
    ..Finally, new drugs have been developed to treat influenza virus, respiratory syncytial virus, parainfluenza virus and adenovirus with some promising results...
  17. ncbi A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children
    Janet A Englund
    Division of Pediatric Infectious Diseases, Allergy, and Rheumatology, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Pediatrics 115:1039-47. 2005
    ..Trivalent inactivated influenza vaccine (TIV) is recommended for all children ages 6 to 23 months. Delivering 2 doses of TIV at least 4 weeks apart to young children receiving this vaccine for the first time is challenging...
  18. ncbi A prospective study of parainfluenza virus type 4 infections in children attending daycare
    Mary P Fairchok
    Department of Pediatrics, Madigan Army Medical Center, Tacoma, WA 98431, USA
    Pediatr Infect Dis J 30:714-6. 2011
    ..PIV-4 was second only to PIV-3, occurring in 9 of 87 (10%) PIV+ illnesses. PIV-4 illnesses were not more severe and not associated with a specific clinical syndrome...
  19. ncbi Self-collection of foam nasal swabs for respiratory virus detection by PCR among immunocompetent subjects and hematopoietic cell transplant recipients
    Angela P Campbell
    University of Washington, Seattle, Washington, USA
    J Clin Microbiol 51:324-7. 2013
    ..004), respectively, and those from 140 URI samples from hematopoietic cell transplantation recipients were 88% and 85% (P = 0.56), respectively...
  20. ncbi Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings
    Jane L Burns
    Department of Pediatrics, Division of Infectious Diseases, University of Washington and Seattle Children s Hospital, USA
    Influenza Other Respi Viruses 6:218-23. 2012
    ..In addition, associations between viral detection and respiratory symptoms are not well described...
  21. ncbi Frequent and prolonged shedding of bocavirus in young children attending daycare
    Emily T Martin
    Center for Clinical and Translational Research, Seattle Children s Research Institute, 1900 Ninth Avenue, Seattle, WA 98101, USA
    J Infect Dis 201:1625-32. 2010
    ..Little is known about human bocavirus (HBoV) persistence and shedding and the association between HBoV detection and the onset and resolution of respiratory symptoms...
  22. ncbi Coronavirus-associated pneumonia in previously healthy children
    Judson Heugel
    Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, WA, USA
    Pediatr Infect Dis J 26:753-5. 2007
    ..Here, we document the clinical courses of 2 previously healthy children with coronavirus-associated pneumonia...
  23. ncbi H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients
    Christian Renaud
    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Emerg Infect Dis 17:653-60; quiz 765. 2011
    ..Emergence of oseltamivir resistance is frequent in immunocompromised patients infected with pandemic (H1N1) 2009 virus and can be associated with a wide range of clinical disease and viral kinetics...
  24. ncbi Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection
    Yae Jean Kim
    Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Semin Respir Crit Care Med 28:222-42. 2007
    ..Clinicians should appreciate the potential for the development of antiviral resistance to influenza antivirals in immunocompromised patients...
  25. ncbi Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
    Su Mi Choi
    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 117:5050-6. 2011
    ..Thus, our data suggest that infection with 2009 influenza A/H1N1 resulted in more severe respiratory disease in HCT recipients compared with seasonal influenza...
  26. ncbi Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?
    Emmanuel B Walter
    Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Vaccine 28:4376-83. 2010
    ..The role of age should be considered when assessing improved vaccines to enhance TIV immunogenicity and effectiveness in younger children...
  27. ncbi Multiple viral respiratory pathogens in children with bronchiolitis
    Hilary E Stempel
    Seattle Children s Hospital Research Institute, University of Washington, Seattle, WA, USA
    Acta Paediatr 98:123-6. 2009
    ..The aim of the study was to describe the frequency of viral pathogens and relative frequency of co-infections in nasal specimens obtained from young children with bronchiolitis receiving care at a children's hospital...
  28. ncbi Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1
    Christian Renaud
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Virol 52:70-8. 2011
    ..However, immunocompromised patients infected with oseltamivir-resistant H1N1 experience potentially more risks of complication and transmissibility with few therapeutic options...
  29. ncbi Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions
    Justin R Ortiz
    Vaccine Development Global Program, PATH, Seattle, WA, United States
    Vaccine 29:4439-52. 2011
    ..Nonetheless, maternal influenza vaccination remains an important and potentially cost-effective approach to decrease influenza morbidity in two high-risk groups - pregnant women and young infants...
  30. ncbi Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations
    Tina Tan
    Division of Infectious Diseases, Northwestern University s Feinberg School of Medicine, The Children s Memorial Hospital, Chicago, IL 60614, USA
    Pediatr Infect Dis J 24:S83-6. 2005
    ....
  31. ncbi Detection of bocavirus in saliva of children with and without respiratory illness
    Emily T Martin
    Center for Clinical and Translational Research, Seattle Children s Research Institute, Washington 98101, USA
    J Clin Microbiol 47:4131-2. 2009
    ..hBoV was detected in saliva samples at asymptomatic enrollment in 3% (5/149) and during respiratory illness in 2% (2/106) of the cases. hBoV was detected in only 1/149 asymptomatic and 0/106 illness nasal samples...
  32. ncbi Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience
    Xuan Qin
    Department of Laboratory Medicine, Microbiology Laboratory, Children s Hospital and Regional Medical Center, NE, Seattle, WA 98105 0371, USA
    Antimicrob Agents Chemother 52:3909-14. 2008
    ..These data have important implications for empirical antimicrobial strategies targeting serious pediatric infections. Further study of this problem is warranted...
  33. ncbi Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infection
    James A Taylor
    Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
    Pediatr Res 68:252-7. 2010
    ..9%, and accuracy of 73.3%. Parental impression is only a moderately accurate predictor of viral URI in children. Our URI symptom score provided a more accurate method for identifying children with viral URIs for clinical studies...
  34. ncbi Emergence of oseltamivir-resistant pandemic H1N1 in an immunocompetent child with severe status asthmaticus
    Christian Renaud
    Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Asthma 48:572-5. 2011
    ..Pandemic influenza A (H1N1) may cause severe illness in pediatric patient with chronic lung disease...
  35. ncbi Clinical disease in children associated with newly described coronavirus subtypes
    Jane Kuypers
    Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
    Pediatrics 119:e70-6. 2007
    ..In this study we examined the prevalence of 4 human coronaviruses, including subtypes OC43, 229E, and the recently described NL63 and HKU1 in a pediatric population presenting to a children's hospital...
  36. ncbi Multitarget PCR for diagnosis of pertussis and its clinical implications
    Xuan Qin
    Microbiology Laboratory, Department of Laboratories and Pathology, A9601, Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
    J Clin Microbiol 45:506-11. 2007
    ..This consensus generating real-time PCR approach permits a sensitive detection, as well as an accurate species identification of the causative Bordetella pathogens for the timely management of patients...
  37. ncbi Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization
    Danielle M Zerr
    Children s Research Institute, and Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
    Pediatrics 121:345-8. 2008
    ..We performed this study to determine the frequency of previous hospitalization among children hospitalized with influenza...
  38. ncbi Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
    Alexander Imhof
    Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Clin Infect Dis 39:743-6. 2004
    ..Minimal inhibitory concentrations were > or =1 microg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis...
  39. ncbi Maternal immunization with inactivated influenza vaccine: rationale and experience
    Janet A Englund
    Department of Pediatrics, Children's Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way NE # 8G, Seattle, WA 98105, USA
    Vaccine 21:3460-4. 2003
    ..Increased influenza vaccine use during pregnancy has the potential to benefit both the woman and her infant...
  40. ncbi BK nephropathy in pediatric hematopoietic stem cell transplant recipients
    Priya S Verghese
    Department of Pediatrics, University of Washington and Seattle Children s Hospital, Seattle, WA 98105, USA
    Pediatr Transplant 13:913-8. 2009
    ....
  41. ncbi Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection
    Caroline J Chantry
    Department of Pediatrics, University of California Davis Medical Center, Sacramento 95817, USA
    Pediatr Infect Dis J 22:1033-9. 2003
    ..The relationships among weight and height growth, viral load and survival in HIV-infected children remain unclear...
  42. ncbi Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency
    Ingrid S Lundgren
    Division of Infectious Diseases, Seattle Children s Hospital, Seattle, WA 98105, USA
    Pediatr Infect Dis J 31:95-7. 2012
    ..We found that 80% of patients receiving only 21 days of antibiotics survived to 12 months beyond hematopoietic cell transplant, whereas only 25% of patients who required longer treatment for PCP survived to stem cell engraftment...
  43. ncbi Influenza A pneumonia presenting as progressive focal infiltrates in a stem cell transplant recipient
    John D Scott
    Department of Medicine, University of Washington, Harborview Medical Center, 325 Ninth Avenue, Box 359938, Seattle, WA 98104 2499, USA
    J Clin Virol 31:96-9. 2004
    ..Stem cell transplant recipients are susceptible to pulmonary infections, including influenza A. Typically, isolated influenza pneumonia has a diffuse, interstitial infiltrate pattern...
  44. ncbi Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness
    Lindsey N Johnson
    Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA
    Pediatr Infect Dis J 23:881-2. 2004
    ..We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients...
  45. ncbi Effectiveness of school-based influenza vaccination
    James C King
    Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
    N Engl J Med 355:2523-32. 2006
    ..Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities...
  46. ncbi Antiviral therapy of influenza
    Janet A Englund
    Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA
    Semin Pediatr Infect Dis 13:120-8. 2002
    ..No direct comparisons of any of these antiviral agents has been performed; all result in clinical improvement approximately 1 to 2 days earlier in otherwise healthy children when therapy is initiated within 48 hours of onset of symptoms...
  47. ncbi Response to changes in antiretroviral therapy after genotyping in human immunodeficiency virus-infected children
    Nicole J Cohen
    Department of Pediatrics, University of Chicago Hospitals, IL, USA
    Pediatr Infect Dis J 21:647-53. 2002
    ..However, medication history alone does not appear to be an adequate alternative to genotyping in choosing salvage regimens in antiretroviral agent-experienced children...
  48. ncbi Duration of immunity against pertussis after natural infection or vaccination
    Aaron M Wendelboe
    Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Pediatr Infect Dis J 24:S58-61. 2005
    ..Further research into the rate of waning of vaccine-acquired immunity will help determine the optimal timing and frequency of booster immunizations and their role in pertussis control...
  49. ncbi Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington
    Emmanouil Galanakis
    Int J Antimicrob Agents 29:609-11. 2007
  50. ncbi Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors
    Janet A Englund
    University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
    Pediatr Infect Dis J 23:15-22. 2004
    ....
  51. ncbi Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants
    John P DeVincenzo
    University of Tennessee, LeBonheur Children s Medical Center, Memphis 38103, USA
    J Infect Dis 190:975-8. 2004
    ..Palivizumab bound to all 371 RSV isolates able to be evaluated, including 25 from active-palivizumab recipients. The palivizumab epitope appears to be highly conserved, even in infants receiving prophylaxis with palivizumab...
  52. ncbi Influenza vaccine for young children: two doses are better than one
    Kathleen Maletic Neuzil
    J Pediatr 149:737-8. 2006
  53. ncbi Role of maternal pertussis antibodies in infants
    Annelies Van Rie
    Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Pediatr Infect Dis J 24:S62-5. 2005
    ..The limited data on neonatal and maternal pertussis immunization are promising and call for further research to reduce the vulnerability of young infants to pertussis disease...
  54. ncbi Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit
    Adrienne G Randolph
    Department of Anesthesia, Harvard Medical School, Boston, MA, USA
    Pediatr Infect Dis J 23:990-4. 2004
    ..Although bacterial pneumonia in this cohort may be more prevalent, overdiagnosis is common...